GeminIQ Website Logo

Viewing HYEX free

Start free trial

Subscribe for full history, 90+ metrics, screener, watchlist...

HEALTHY EXTRACTS INC.

HYEX

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Deposits Assets
------000000
Assets
Cash
000000000000
Accounts Receivable Net Current
100000000000
Inventory Net
111111111222
Assets Current
Assets Current
211221222222
Notes Receivable Net
---00-------
Deposits Assets Current
--00000-----
Deferred Offering Costs
000000000000
Operating Lease Right Of Use Asset
--0000000000
Acquisition Costs Cumulative
----------00
Finite Lived Intangible Assets Net
444000000000
Deposits Assets Noncurrent
0000000-----
Goodwill
262121000000000
Long Term Investments
---24--------
Finite Lived Patents Gross
111111111111
Other Assets
3126262411111111
Assets
3327282622222333
Liabilities And Stockhold…
Accounts Payable Current
000000000000
Liabilities Current
822112122222
Interest Payable Current
000000000000
Accrued Liabilities Current
101000000000
Operating Lease Liability Current
000000000000
Convertible Notes Payable Current
000000111111
Operating Lease Liability Noncurrent
000000000000
Notes Payable Current
111000000000
Derivative Liabilities
000111101100
Liabilities Noncurrent
22211-1-----
Liabilities
103422-2-----
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Stockholders Equity
Stockholders Equity
2224242400010011
Additional Paid In Capital
464444442019191919191919
Treasury Stock Value
-4-0-0-0-0-0-0-0--0-
Retained Earnings Accumulated Deficit
-20-20-20-20-20-20-19-19-19-19-18-18
Liabilities And Stockholders Equity
3327282622222333
Preferred Stock Par Or Stated Value Per Share
0.0010.00100.0010.0010.00100.0010.0010.00100.001
Preferred Stock Shares Authorized
757575757575757575757575
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.00100.0010.0010.00100.0010.0010.00100.001
Common Stock Shares Authorized
50505050505050505050502,500
Common Stock Shares Issued
151717173333333354
Shares Outstanding
151717173333333354
Treasury Stock Common Shares
--0-0000----

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026101.51%21.97%10.42%---------
2025-25.42%-36.45%-20.40%12.14%-53.57%-30.36%-6.13%-28.30%6.13%-31.29%38.04%31.90%
202425.00%58.50%102.50%-7.16%-11.60%-19.75%50.36%15.66%-13.25%54.64%2.58%-9.79%
2023-------8.00%-33.33%-53.50%-10.31%-10.31%12.11%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.20
0.69
0.79
1.47
1.81
0.63
1.24
1.04
0.84
0.76
1.13
1.18
Quick Ratio
0.12
0.36
0.29
0.65
0.53
0.14
0.22
0.18
0.21
0.13
0.16
0.23
Working Capital
-6.71M
-496.94K
-360.85K
554.71K
698.83K
-870.30K
319.64K
67.28K
-335.88K
-583.14K
219.25K
288.60K
Leverage & Debt
Debt to Equity
0.45
0.14
0.16
0.09
4.22
38.85
4.79
2.07
5.21
16.18
1.76
1.58
Interest Coverage TTM
-2.49
-1.46
-2.61
-5.99
-3.30
-1.12
-3.51
-1.27
-4.45
-10.17
-7.54
-6.73
Debt Ratio
0.31
0.12
0.14
0.08
0.81
0.97
0.83
0.67
0.84
0.94
0.64
0.61
Efficiency & Turnover
Asset Turnover TTM
0.32
0.35
0.30
0.23
1.27
1.34
1.24
1.15
1.09
0.94
0.92
0.92
Days Sales Outstanding TTM
19.87
11.38
8.04
2.78
5.44
5.11
2.43
8.01
13.36
11.37
10.00
15.43
Receivables Turnover TTM
18.37
32.08
45.40
131.16
67.14
71.37
150.24
45.54
27.31
32.11
36.49
23.66
Per Share Metrics
Diluted EPS TTM
-
-0.04
-0.09
-0.24
-0.29
-0.13
-0.28
-0.16
-0.37
-0.94
-0.85
-0.51
Free Cash Flow Per Share TTM
0.03
0.01
0.01
-0.01
0.05
0.11
0.09
0.10
0.06
-0.02
-0.14
-0.00
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
58.50%
57.52%
53.69%
55.66%
63.59%
57.45%
61.39%
65.78%
64.97%
68.46%
65.24%
58.15%
Operating Profit Margin TTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Net Profit Margin TTM
-19.21%
-13.15%
-19.53%
-48.91%
-27.95%
-11.27%
-27.00%
-16.68%
-38.93%
-107.63%
-99.48%
-59.13%
Growth Metrics
Net Revenue Growth (1Y)
76.79%
54.70%
44.93%
13.94%
13.11%
31.10%
25.24%
18.24%
18.38%
10.58%
10.41%
22.83%
Net Income Growth (1Y)
21.48%
80.52%
4.81%
234.20%
-18.78%
-86.27%
-66.01%
-66.65%
-21.48%
76.01%
151.54%
-17.78%
EPS Growth (1Y)
-74.11%
-68.05%
-81.43%
-40.78%
-22.61%
-86.39%
-66.41%
3,854.61%
8,961.77%
20,416.65%
144.93%
-19.95%
Valuation Metrics
P/E TTM
-29.41
-39.08
-29.10
-17.49
-7.08
-15.33
-8.93
-20.75
-6.85
-2.40
-8.60
-1,527.81
P/B TTM
1.41
1.11
1.07
1.19
13.15
95.85
18.28
12.66
18.71
43.59
22.28
2,190.31
P/S TTM
5.65
5.14
5.68
8.55
1.98
1.73
2.41
3.46
2.67
2.58
8.56
903.35
Market Cap
31.69M
26.69M
25.64M
28.63M
6.28M
5.80M
7.50M
10.16M
7.48M
6.61M
21.27M
2.24B
Enterprise Value
32.43M
27.78M
26.85M
28.73M
6.48M
6.17M
7.92M
10.78M
8.15M
7.45M
22.22M
2.24B
Calculated Values
Free Cash Flow TTM
500.27K
211.47K
165.52K
-160.76K
171.40K
323.27K
281.97K
295.71K
175.55K
-54.15K
-415.75K
-618.34K
Net Debt
737.87K
1.09M
1.21M
98.37K
195.44K
374.85K
421.27K
620.56K
667.44K
836.53K
950.25K
950.88K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-07-19Purchase
Owner: Swanson, Donald William
Title: President
Shares: 13,075,920
Price/Share: $23536656.00
Value: $307,763,430,923,520.00
Shares Owned: 13,075,920
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Start free trial
No institutional ownership data available.

HEALTHY EXTRACTS INC. (HYEX) — SEC Financial Statements & Analysis

HEALTHY EXTRACTS INC. (HYEX) is a medicinal chemicals & botanical products company, incorporated in NV. HEALTHY EXTRACTS INC. trades on OTC as: HYEX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), HEALTHY EXTRACTS INC. reported a 76.79% year-over-year revenue growth, a Gross Profit Margin of 58.50% (TTM), a Debt-to-Equity ratio of 0.45x, a Price-to-Sales (P/S) ratio of 5.65x (TTM), a Price-to-Book (P/B) ratio of 1.41x (TTM), at a market cap of $31.69M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
76.79%
Gross Profit Margin TTM
58.50%
Debt To Equity
0.45x
P/S TTM
5.65x
P/B TTM
1.41x
Market Cap
$31.69M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is HEALTHY EXTRACTS INC. in?

HEALTHY EXTRACTS INC. (HYEX) operates in the Medicinal Chemicals & Botanical Products industry.

What is HYEX's market cap?

HEALTHY EXTRACTS INC. (HYEX) has a market capitalization of $31.69M as of 2026-06-30.

What exchange does HYEX trade on?

HEALTHY EXTRACTS INC. (HYEX) trades on the OTC.

Where is HEALTHY EXTRACTS INC. incorporated?

HEALTHY EXTRACTS INC. is incorporated in NV.

Companies in Medicinal Chemicals & Botanical Products

DFTXDefinium Therapeutics, Inc.TRLVTrulieve Cannabis Corp.CRONCronos Group Inc.TLRYTilray Brands, Inc.CGCCanopy Growth CorpUSNAUSANA HEALTH SCIENCES INC

Wall Street's data.
Main Street's price.

Start 7-day free trial